Skip to content

Insider · CIK 0001762572

Jason Hoitt

officer

Files at STOK (Stoke Therapeutics, Inc.). First filing Mar 19, 2026, latest Mar 19, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $119k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

STOK: Stoke Therapeutics, Inc.

STOKOct 9, 2026 · close 24.74

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
STOKsell 5
Stoke Therapeutics, Inc.
$119k
3,712 shares
-27%+457% from low-14% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 17, 2026STOK
Stoke Therapeutics, Inc.
SOpen-market sale
Common Stock
-1,033$32.74$34k12,955Mar 19, 2026
Mar 17, 2026STOK
Stoke Therapeutics, Inc.
SOpen-market sale
Common Stock
-748$33.38$25k12,207Mar 19, 2026
Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SOpen-market sale
Common Stock
-1,762$31.28$55k10,445Mar 19, 2026
Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SOpen-market sale
Common Stock
-139$31.79$4,41910,306Mar 19, 2026
Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SOpen-market sale
Common Stock
-30$32.85$98610,276Mar 19, 2026
Mar 15, 2026STOK
Stoke Therapeutics, Inc.
MOption exercise
Common Stock
+10,000$0.00$013,988Mar 17, 2026
Mar 15, 2026STOK
Stoke Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-10,000$0.00$030,000Mar 17, 2026
Feb 17, 2026STOK
Stoke Therapeutics, Inc.
AGrant or award
Employee Stock Option (Right to Buy)derivative
+72,000$0.00$072,000Feb 19, 2026
Feb 17, 2026STOK
Stoke Therapeutics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+48,000$0.00$048,000Feb 19, 2026

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jason Hoitt: insider trades and track record | InsiderTell